Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Cuschieri

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Journal of Virology|April 29, 2005
Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -bItzel E Calleja-Macias, Mina Kalantari, Bruce Allan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal of Medical Virology|September 2, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningMarc Arbyn, Kate Cuschieri, Jesper Bonde, et al.
Journal of Medical Virology|April 25, 2026
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical ScreeningEmel Yilmaz, Gerald Laurence Murray, Prisha Balgovind, et al.
Journal of Virology|October 18, 2005
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias, Luisa L Villa, Jose C Prado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 YearsFrederique J Vink, Chris J L M Meijer, Albertus T Hesselink, et al.
Virology|July 26, 2005
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado, Itzel E Calleja-Macias, Hans-Ulrich Bernard, et al.
International Journal of Cancer|August 8, 2019
FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide studyFrederique J Vink, Chris J L M Meijer, Gary M Clifford, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Journal of Virology|April 29, 2005
Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -bItzel E Calleja-Macias, Mina Kalantari, Bruce Allan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal of Medical Virology|September 2, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningMarc Arbyn, Kate Cuschieri, Jesper Bonde, et al.
Journal of Medical Virology|April 25, 2026
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical ScreeningEmel Yilmaz, Gerald Laurence Murray, Prisha Balgovind, et al.
Journal of Virology|October 18, 2005
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias, Luisa L Villa, Jose C Prado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 YearsFrederique J Vink, Chris J L M Meijer, Albertus T Hesselink, et al.
Virology|July 26, 2005
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado, Itzel E Calleja-Macias, Hans-Ulrich Bernard, et al.
International Journal of Cancer|August 8, 2019
FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide studyFrederique J Vink, Chris J L M Meijer, Gary M Clifford, et al.
Pageof 14